Drug-eluting Balloon Catheters Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of Drug-eluting Balloon Catheters Market
The drug-eluting balloon catheters market size was valued at USD 529.4 billion in 2021, and the market is now projected to grow from USD 615.2 billion in 2022 to USD 1,119.4 billion by 2029, exhibiting a CAGR of 8.9% during the forecast period of 2023-2030.
Government has put restrictions on social gatherings, events and moving out from home which make the people homesick. Numerous companies are encountering hurdles due to covid pandemic as the outbreak situation has curtailed production and supply chain which has hindered the market switched to treating covid patients as priority over the other procedures which led the drug-eluting balloon catheters market growth. Additionally, manpower shortages affected manufacturing plants and slowed production due to movement restrictions and lockdowns in several regions. Stopped providing on-site maintenance and installations market growth sputtered amid the pandemic.
Drug-eluting stent drawbacks such inadequate stent apposition, unfavorable medication interactions, and elevated in-stent thrombosis rates can be avoided with the use of these catheters. These devices are a viable treatment option for coronary artery disease. This boosted the demand for products in this industry and the necessity for angioplasty procedures.
Minimally invasive techniques also include angioplasty surgery. These operations serve as a substitute for open heart surgery. Compared to traditional procedures, they are more advantageous since they shorten hospital stays and speed up healing. Additionally, these catheters are now used more often in angioplasty procedures for a variety of cardiovascular diseases due to their numerous benefits over drug-eluting stents in targeted drug delivery. They offer superior clinical and angiographic results.
Comprehensive Analysis of Drug-eluting Balloon Catheters Market
The drug-eluting balloon catheters market and healthcare industry is rising at an exponential rate due to its market segmentation. This market expansion effectively provides a detailed regional assessments considering the dominant supply and demand forces that impact the pharmacy benefit management industry. These segmentations are methodically segregated by drug, by indication and by end users. The Drug segmentations include Paclitaxel, Sirolimus, and Others, By Indication segmentations include Coronary Intervention and Peripheral Intervention, By End-user segmentations include Hospitals & ASCs and Specialty Clinics and Catheterization Laboratories.
The North America region lead the drug-eluting balloon catheters market by benefitting a market size of USD 256.9 billion in 2021 due to adoption of advanced technology in treatment.
The top players in the market play a crucial role in the healthcare industry assuring industrial prospectus growth and setting market standards. These players include, Medtronic (Ireland), Koninklijke Philips N.V. (Netherlands), Boston Scientific Corporation (U.S.), BD (U.S.), B. Braun SE (Germany), Meril Life Sciences Pvt. Ltd. (India), BIOTRONIK (Germany), Cordis (U.S.), MicroPort Medical (Group) Co., Ltd. (China) these market players provide a level-playing competitive landscape.
In January 2021, For the Reewarm PTX Drug Coated Balloon PTA catheter used for femoral popliteal artery indication during percutaneous transluminal angioplasty, MicroPort Medical (Group) Co., Ltd. been granted an EU CE mark.
Segmentation Table
ATTRIBUTE
DETAILS
Study Period
2018-2029
Base Year
2021
Estimated Year
2022
Forecast Period
2022-2029
Historical Period
2018-2020
Unit
Value (USD Million)
Segmentation
By Drug, Indication, End-user, and Region
By Drug
Paclitaxel
Sirolimus
Others
By Indication
Coronary Intervention
Peripheral Intervention
By End-user
Hospitals & ASCs
Specialty Clinics and Catheterization Laboratories
By Geography
North America (U.S. and Canada)
Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
Rest of the WorldPlease Note: It will take 5-6 business days to complete the report upon order confirmation.
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
- 4. Key Insights
- 4.1. Prevalence of Peripheral Artery Disease (PAD), in 2021 – By Region
- 4.2. Pipeline Analysis
- 4.3. New Product Launches
- 4.4. Key Industry Developments
- 4.5. Impact of COVID-19 on the Market
- 5. Global Drug-eluting Balloon Catheters Market Analysis, Insights and Forecast, 2018-2029
- 5.1. Market Analysis, Insights and Forecast – By Drug
- 5.1.1. Paclitaxel
- 5.1.2. Sirolimus
- 5.1.3. Others
- 5.2. Market Analysis, Insights and Forecast – By Indication
- 5.2.1. Coronary intervention
- 5.2.2. Peripheral intervention
- 5.3. Market Analysis, Insights and Forecast – By End-user
- 5.3.1. Hospitals & ASCs
- 5.3.2. Specialty Clinics and Catheterization Laboratories
- 5.4. Market Analysis, Insights and Forecast – By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Rest of the World
- 6. North America Drug-eluting Balloon Catheters Market Analysis, Insights and Forecast, 2018-2029
- 6.1. Market Analysis, Insights and Forecast – By Drug
- 6.1.1. Paclitaxel
- 6.1.2. Sirolimus
- 6.1.3. Others
- 6.2. Market Analysis, Insights and Forecast – By Indication
- 6.2.1. Coronary intervention
- 6.2.2. Peripheral intervention
- 6.3. Market Analysis, Insights and Forecast – By End-user
- 6.3.1. Hospitals & ASCs
- 6.3.2. Specialty Clinics and Catheterization Laboratories
- 6.4. Market Analysis, Insights and Forecast – By Country
- 6.4.1. U.S.
- 6.4.2. Canada
- 7. Europe Drug-eluting Balloon Catheters Market Analysis, Insights and Forecast, 2018-2029
- 7.1. Market Analysis, Insights and Forecast – By Drug
- 7.1.1. Paclitaxel
- 7.1.2. Sirolimus
- 7.1.3. Others
- 7.2. Market Analysis, Insights and Forecast – By Indication
- 7.2.1. Coronary intervention
- 7.2.2. Peripheral intervention
- 7.3. Market Analysis, Insights and Forecast – By End-user
- 7.3.1. Hospitals & ASCs
- 7.3.2. Specialty Clinics and Catheterization Laboratories
- 7.4. Market Analysis, Insights and Forecast – By Country/Sub-region
- 7.4.1. U.K.
- 7.4.2. Germany
- 7.4.3. France
- 7.4.4. Spain
- 7.4.5. Italy
- 7.4.6. Scandinavia
- 7.4.7. Rest of Europe
- 8. Asia Pacific Drug-eluting Balloon Catheters Market Analysis, Insights and Forecast, 2018-2029
- 8.1. Market Analysis, Insights and Forecast – By Drug
- 8.1.1. Paclitaxel
- 8.1.2. Sirolimus
- 8.1.3. Others
- 8.2. Market Analysis, Insights and Forecast – By Indication
- 8.2.1. Coronary intervention
- 8.2.2. Peripheral intervention
- 8.3. Market Analysis, Insights and Forecast – By End-user
- 8.3.1. Hospitals & ASCs
- 8.3.2. Specialty Clinics and Catheterization Laboratories
- 8.4. Market Analysis, Insights and Forecast – By Country/Sub-region
- 8.4.1. Japan
- 8.4.2. China
- 8.4.3. India
- 8.4.4. Australia
- 8.4.5. Southeast Asia
- 8.4.6. Rest of Asia Pacific
- 9. Rest of the World Drug-eluting Balloon Catheters Market Analysis, Insights and Forecast, 2018-2029
- 9.1. Market Analysis, Insights and Forecast – By Drug
- 9.1.1. Paclitaxel
- 9.1.2. Sirolimus
- 9.1.3. Others
- 9.2. Market Analysis, Insights and Forecast – By Indication
- 9.2.1. Coronary intervention
- 9.2.2. Peripheral intervention
- 9.3. Market Analysis, Insights and Forecast – By End-user
- 9.3.1. Hospitals & ASCs
- 9.3.2. Specialty Clinics and Catheterization Laboratories
- 10. Competitive Analysis
- 10.1. Global Market Share Analysis (2021)
- 10.2. Company Profiles (Overview, Product, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
- 10.2.1. Medtronic
- 10.2.1.1. Overview,
- 10.2.1.2. Product,
- 10.2.1.3. SWOT Analysis,
- 10.2.1.4. Recent Developments,
- 10.2.1.5. Strategies,
- 10.2.1.6. financials (Based on Availability)
- 10.2.2. Koninklijke Philips N.V.
- 10.2.2.1. Overview,
- 10.2.2.2. Product,
- 10.2.2.3. SWOT Analysis,
- 10.2.2.4. Recent Developments,
- 10.2.2.5. Strategies,
- 10.2.2.6. financials (Based on Availability)
- 10.2.3. Boston Scientific Corporation
- 10.2.3.1. Overview,
- 10.2.3.2. Product,
- 10.2.3.3. SWOT Analysis,
- 10.2.3.4. Recent Developments,
- 10.2.3.5. Strategies,
- 10.2.3.6. financials (Based on Availability)
- 10.2.4. BD
- 10.2.4.1. Overview,
- 10.2.4.2. Product,
- 10.2.4.3. SWOT Analysis,
- 10.2.4.4. Recent Developments,
- 10.2.4.5. Strategies,
- 10.2.4.6. financials (Based on Availability)
- 10.2.5. B. Braun SE
- 10.2.5.1. Overview,
- 10.2.5.2. Product,
- 10.2.5.3. SWOT Analysis,
- 10.2.5.4. Recent Developments,
- 10.2.5.5. Strategies,
- 10.2.5.6. financials (Based on Availability)
- 10.2.6. Meril Life Sciences Pvt. Ltd.
- 10.2.6.1. Overview,
- 10.2.6.2. Product,
- 10.2.6.3. SWOT Analysis,
- 10.2.6.4. Recent Developments,
- 10.2.6.5. Strategies,
- 10.2.6.6. financials (Based on Availability)
- 10.2.7. BIOTRONIK
- 10.2.7.1. Overview,
- 10.2.7.2. Product,
- 10.2.7.3. SWOT Analysis,
- 10.2.7.4. Recent Developments,
- 10.2.7.5. Strategies,
- 10.2.7.6. financials (Based on Availability)
- 10.2.8. Cordis
- 10.2.8.1. Overview,
- 10.2.8.2. Product,
- 10.2.8.3. SWOT Analysis,
- 10.2.8.4. Recent Developments,
- 10.2.8.5. Strategies,
- 10.2.8.6. financials (Based on Availability)
- 10.2.9. MicroPort Medical (Group) Co., Ltd.
- 10.2.9.1. Overview,
- 10.2.9.2. Product,
- 10.2.9.3. SWOT Analysis,
- 10.2.9.4. Recent Developments,
- 10.2.9.5. Strategies,
- 10.2.9.6. financials (Based on Availability)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook